Rare diseases
Investigational molecules
Locations
Solnavagen 1 E, S:t Matteus, 113 65 Stockholm, Sweden
Research activity includes studies in major depressive disorder, with a focus on depressive symptoms in people affected by cancer. The sponsor also supports work involving psilocybin for cancer-related depression.
Interest in this area extends to symptom relief and mental health outcomes in patients with serious medical illness.
Region Stockholm – SLSO runs clinical trials in conditions such as Multiple sclerosis, Relapsing multiple sclerosis, Type 2 diabetes mellitus, Obesity, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Randomized Study of Tolebrutinib Versus Rituximab in Adults with Multiple Sclerosis
SwedenTesting the Immune Response to Trivalent Inactivated Influenza Vaccine in People with Obesity and Type 2 Diabetes
SwedenStudy on Psilocybin for Treating Depression in Cancer Patients
SwedenTesting Remdesivir in Hospitalized Adult Patients with Tick-Borne Encephalitis to Measure Effects on Brain Cell Damage
SwedenStudy of rituximab for reducing pain in patients with fibromyalgia caused by autoantibodies
SwedenStudy on How Exenatide Affects Early Parkinson's Disease Progression in Patients
SwedenIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
